Fresh questions.
A clearer view of care.
New findings, real decisions and the people behind the progress.
The next move
When should treatment begin? Which information deserves trust?
What makes a healthy habit possible? This week's stories connect
evidence with the choices that shape everyday life.
CDC / Unsplash. Polio-testing laboratory context; not an Ebola trial.
Ebola research: candidates move towards an
outbreak trial
On 4 November, WHO reported a recommendation to
add two vaccine candidates to the Tumaini trial in the
Democratic Republic of the Congo, subject to national
approvals. Oxford and the Serum Institute of India's
ChAdOx1 candidate and Moderna's mRNA-1469 are
designed against Bundibugyo virus. [5]
The trial uses ring vaccination among contacts of
confirmed cases. WHO also describes treatment
research through PARTNERS, including MBP134 and
remdesivir, with maftivimab planned for addition.
Vaccine results are expected in early 2027. These
developments are about evaluation; protection and
improved survival have not yet been established by the
announced steps. [5]
Climate and health: the scale of preventable harm
A WHO analysis released on 4 November estimates that
global expansion of six climate-and-health actions could
prevent 1.6 million deaths annually. The measures
include heat warnings, resilient drinking water,
sanitation, handwashing, cleaner household energy and
fossil-fuel pricing. [6]
The report estimates economic welfare benefits of
US$3.9 trillion a year, alongside separate fiscal benefits.
Those categories should not be casually added as
though they describe one interchangeable return. The
findings are modelled projections; WHO notes
uncertainty, aspirational scale-up and limitations in the
evidence. Implementation determines whether projected
benefits become real. [6]
The people and products behind the week
Our professional highlight looks at Steven Rosenberg's
pursuit of cell-based cancer treatments and the teams
and participants who make that work possible. The
product page examines a specified wound-care
combination, with its commercial concept clearly
identified. Historical research and product
announcements retain their original dates.
FRESH QUESTIONS. CLEAR EVIDENCE. A HUMAN PERSPECTIVE.